| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/15/2004 | US20040137561 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/15/2004 | US20040137557 Remodeling and glycoconjugation of peptides |
| 07/15/2004 | US20040137530 for diagnostic assays/genetically engineering drugs and vaccines |
| 07/15/2004 | US20040137529 Identifying prions in infectious conformations in mammalian nervous system tissue; diagnosing spongiform encephalopathies in animals |
| 07/15/2004 | US20040137528 Fragments of fluorescent proteins for protein fragment complementation assays |
| 07/15/2004 | US20040137523 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 07/15/2004 | US20040137522 Genes and proteins altering Tau-related neurodegeneration |
| 07/15/2004 | US20040137521 Method for apo clll measurement in apo b and non apo b containing particles |
| 07/15/2004 | US20040137518 CRYSTALLIZED PPARa LIGAND BINDING DOMAIN POLYPEPTIDE AND SCREENING METHODS EMPLOYING SAME |
| 07/15/2004 | US20040137516 DNA sequences from staphylococcus aureus bacteriophage 44AHJD that encode anti-microbial polypeptides |
| 07/15/2004 | US20040137514 Use of antibodies against specific mhc-peptide complexes |
| 07/15/2004 | US20040137512 Malaria plasmodium antigen polypeptide se36, method of purifyng the same and vaccine and diagnostic with the use of the thus obtained antigen |
| 07/15/2004 | US20040137510 by screening genomic DNA for mutations; solid phase synthesis; kits |
| 07/15/2004 | US20040137509 Nucleic acid encoding human G protein-coupled receptor |
| 07/15/2004 | US20040137506 for drug screening compunds that affect inappropriate regulation, development, or physiology of antigen presenting cells |
| 07/15/2004 | US20040137503 for analysing allelic variation a gene, and using polymorphism in treatment of diseases with gene-specific drugs |
| 07/15/2004 | US20040137500 for drug screening G-protein coupled receptors (GPCRs) compounds; genetic engineering |
| 07/15/2004 | US20040137496 Genes encoding sulfate assimilation proteins |
| 07/15/2004 | US20040137495 Meg-4 protein |
| 07/15/2004 | US20040137494 using expressed sequence tags (ESTs); open reading frames; genetic engineering; kits |
| 07/15/2004 | US20040137492 Novel polypeptide |
| 07/15/2004 | US20040137487 hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target |
| 07/15/2004 | US20040137469 Peptide Nucleic Acids (PNA); an acid forming cleavable linker and a PNA dimer comprising an N-terminal base labile protecting group, cleavably linked to the solid support through the cleavable linker |
| 07/15/2004 | US20040137467 NPC1L1 (NPC3) and methods of use thereof |
| 07/15/2004 | US20040137466 utilizing conserved regions of greater than or equal to 4 amino acids in length for use in isolating/identifying gene orthologs from different plant families |
| 07/15/2004 | US20040137450 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 07/15/2004 | US20040137448 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosis and treatment of cell proliferative, neurological, developmental, and autoimmune/inflammatory disorders |
| 07/15/2004 | US20040137443 Novel clock gene promoter |
| 07/15/2004 | US20040137438 Encoding transporter of the inner mitochondrial membrane; able to inhibit the expression of a MCF (mitochondrial carrier family) in a host cell in antisense orientation to a promoter; use in modification of transport properties |
| 07/15/2004 | US20040137437 Human source leading sequence, gene vector and gene expression strategy |
| 07/15/2004 | US20040137435 Human abc transporter expressed in liver,atil |
| 07/15/2004 | US20040137434 Novel nucleic acids and polypeptides |
| 07/15/2004 | US20040137433 CNG3B: a novel cyclic nucleotide-gated cation channel |
| 07/15/2004 | US20040137429 Of given nucleotide sequence; Complexed with a toxin moiety; Use in treating human immunodeficiency virus (HIV) |
| 07/15/2004 | US20040137426 Gp41 peptides and methods based thereon for inhibiting HIV fusion to target cells |
| 07/15/2004 | US20040137424 Expression cassette comprising a promoter sequence which enables transcription of a minus strand RNA; Hepatitis C |
| 07/15/2004 | US20040137423 Compositions and methods for modulating HDL cholesterol and triglyceride levels |
| 07/15/2004 | US20040137421 Deposition of the protein in the follicular dendritic cell of a non-human animal and detection by histology, electrophoresis or binding assay |
| 07/15/2004 | US20040137091 Unhydrolyzed and hydrolyzed jojoba protein having high simmondsin concentration of about 11-18% by weight simmondsin 2-(cyanomethylene)-3-hydroxy-4,5-dimethoxy-cyclohexyl-glucoside); cosmetics;detergents; films; sanitizers shampoos |
| 07/15/2004 | US20040137074 Osteoprotegerin in milk |
| 07/15/2004 | US20040137017 amino acid sequence of subunit A of a cholera toxin (CT-A) or a fragment of the amino acid sequence of subunit A of an Escherichia coli heat labile toxin (LT-A) or a fragment, where in Ser-63 and Arg-192 are replaced with another amino acid |
| 07/15/2004 | US20040137016 glycosylated or is partially glycosylated ; mutant pre-S in which one or both asparagines of a wild-type pre-S at amino acid position 15 or 123 are substituted by specific amino acids |
| 07/15/2004 | US20040137015 equine influenza virus genome segment confers at least one identifying phenotype of a cold-adapted equine influenza virus on the reassortant virus, and genetically-engineered equine influenza viruses, produced through reverse genetics |
| 07/15/2004 | US20040137010 gp120 and a nucleic acid aptamer that binds to gp120 and induces gp120 to undergo a conformational shift whereby an epitope to a membrane bound receptor is exposed that is capable of eliciting a humoral immune response |
| 07/15/2004 | US20040137009 DNA encoding a derivative of a human interferon- alpha selected from DNA encoding a protein in which one or more amino acid residues of the protein encoded by the above DNA have been replaced, deleted, and/or added |
| 07/15/2004 | US20040137008 Non-splicing variants of gp350/220 |
| 07/15/2004 | US20040137007 includes polypeptides that contain at least one antigenic portion of a Chlamydia antigen and DNA sequences encoding such polypeptides |
| 07/15/2004 | US20040137006 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells |
| 07/15/2004 | US20040137005 Chlamydia protein, sequence and uses thereof |
| 07/15/2004 | US20040136999 Melanoma antigens and methods of use |
| 07/15/2004 | US20040136995 antibody, or fragment thereof, that specifically binds an ACT-4-h-1 receptor; has different binding specificity than a monoclonal antibody generated by hybridoma HBL106 |
| 07/15/2004 | US20040136987 Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction |
| 07/15/2004 | US20040136985 Methods of modifying behavior of CD9-expressing cells |
| 07/15/2004 | US20040136984 Mammalian galanin receptors |
| 07/15/2004 | US20040136981 isolated polypeptide; screening of compounds useful for treatment fo pathologic states in which histamine is involved; expression vector; host cell |
| 07/15/2004 | US20040136978 relates to the surprising finding that overexpression of ABIN prevents TNF-induced lethal hepatitis in mice |
| 07/15/2004 | US20040136963 Simian adenovirus vectors and methods of use |
| 07/15/2004 | US20040136955 Modified asialo-interferons and uses thereof |
| 07/15/2004 | US20040136954 Methods and compositions for modulating T helper (Th) cell development and function |
| 07/15/2004 | US20040136952 with water-soluble polymers, e.g., poly(ethylene glycol); coupling with amino-terminal amino acid located remotely from one or more receptor-binding domains of said cytokine, chemokine, growth factor or polypeptide hormone, or antagonist thereof |
| 07/15/2004 | US20040136951 Death domain containing receptor 5 |
| 07/15/2004 | US20040136950 enhancing apoptosis induced by a TNF-family ligand, which involves administering to a cell that expresses the DR4 polypeptide an effective amount of an agonist capable of increasing DR4 mediated signaling |
| 07/15/2004 | US20040136926 comprises a tooth enamel binding region of a salivary protein and wherein the second segment comprises an antimicrobial polypeptide; bifunctional hybrid molecules provide sustained release of antimicrobial agent when applied to tooth surface |
| 07/15/2004 | US20040136907 Compounds with binding affinity for both alpha v beta 3 and somatostatin receptors; arginine, glycine, aspartic acid; improved overall affinity for tumors |
| 07/15/2004 | DE10300361A1 Bohrhaltige Peptidverbindung Bohrhaltige peptide compound |
| 07/15/2004 | DE10260537A1 Peptide mit hohem Cysteingehalt Peptides with high cysteine |
| 07/15/2004 | DE10147991B4 Verfahren zur Diagnose von chronisch entzündlichen Darmerkrankungen A method of diagnosing inflammatory bowel disease |
| 07/15/2004 | CA2774928A1 Binding agents which inhibit myostatin |
| 07/15/2004 | CA2756797A1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 07/15/2004 | CA2511625A1 Modified vaccinia ankara expressing p53 in cancer immunotherapy |
| 07/15/2004 | CA2511522A1 Novel proteins and use thereof |
| 07/15/2004 | CA2511520A1 Mammalian cell culture processes for protein production |
| 07/15/2004 | CA2511494A1 Non-hypertensive polyethylene glycol-modified hemoglobin as oxygen carrier |
| 07/15/2004 | CA2511436A1 Centrosome-associated protein and applications thereof |
| 07/15/2004 | CA2511357A1 Crystalline liver x receptor beta protein |
| 07/15/2004 | CA2511245A1 Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof |
| 07/15/2004 | CA2511243A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 07/15/2004 | CA2511213A1 Chimeric protein for the screening of agonists and antagonists of cell signalling pathways that are dependent on g-protein-coupled receptors |
| 07/15/2004 | CA2511186A1 Method for altering the content of reserve substances in plants |
| 07/15/2004 | CA2511012A1 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 07/15/2004 | CA2510884A1 Fluorescent proteins from copepoda species and methods for using same |
| 07/15/2004 | CA2510315A1 Antibodies against gpr64 and uses thereof |
| 07/15/2004 | CA2510311A1 Novel therapeutic targets in cancer |
| 07/15/2004 | CA2510297A1 Mag derivatives, compositions, and methods of use thereof |
| 07/15/2004 | CA2510173A1 Vaccine compositions and methods |
| 07/15/2004 | CA2510011A1 Recessive plant viral resistance results from mutations in translation initiation factor eif4e |
| 07/15/2004 | CA2509999A1 Btl-ii nucleic acids, proteins, and antibodies |
| 07/15/2004 | CA2509568A1 Spliced variants of lgr6 |
| 07/15/2004 | CA2508944A1 Novel compositions and methods in cancer |
| 07/15/2004 | CA2508228A1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 07/15/2004 | CA2489590A1 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/15/2004 | CA2485348A1 Dna vaccines against hantavirus infections |
| 07/14/2004 | EP1437592A1 Novel screening method using prokineticin receptor |
| 07/14/2004 | EP1437413A1 Method of expressing genetically modified protein carrying sugar chain having sialic acid added thereto in insect cells |
| 07/14/2004 | EP1437412A1 Genes participating in the synthesis of fatty acid having trans-11-,cis-13- condjugated double bond and utilization thereof |
| 07/14/2004 | EP1437410A1 Novel selenocystein-containing proteins |
| 07/14/2004 | EP1437409A1 Method of imparting or controlling fertility with the use of fertility restoring gene for rice bt-male sterility cytoplasm and method of judging the existence of fertility restoring gene |
| 07/14/2004 | EP1437400A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 07/14/2004 | EP1437366A1 MHC antigen complexes for detecting and purifying antigen-specific T cells |
| 07/14/2004 | EP1437364A2 Polypeptide binding to the androgen receptor and its potential use for treating breast cancer |